Generics 48

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Carboplatin manufacturers

48 products found

Filters

Filters

Filters , active

Country of origin : Uae

Clear all

48 products found

carboplatin

Concentrate for solution for infusion 10 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Germany
Available for
Licensing with supply, Distribution only
Manufacturer #16717
They've been serving and assisting customers in the healthcare business in Regulatory Affairs and Pharmacovigilance for over 30 years. This sphere of action covers many countries around the world. They look after their local and European consumers and the supply chain by providing high-quality products for internationalization strategies.

Manufacturer usually replies in 14 days

carboplatin

Injection 150 mg, 450 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
FDA
Manufacturer #20861

Manufacturer usually replies in 4 days

carboplatin

Solution for infusion Single Dose Vial

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #12319

Manufacturer usually replies in 5 days

carboplatin

Injection 50 mg/5 ml, 150 mg/15 ml,450 mg/45 ml, 600 mg/60 ml, 1 g/100 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #15176

Manufacturer usually replies in 5 days

carboplatin

Vials, injection 50 mg/5 ml, 150 mg/15 ml, 450 mg/45 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Manufacturer #2722
It originally entered the pharmaceutical industry in 1987, when it introduced blood derivative products to Europe and became the exclusive distributor for prominent European brands. Oncology, hematology, dermatology, radiology, rheumatology, immunology, and OTC products are the seven main therapeutic fields.

Manufacturer usually replies in 6 days

carboplatin

Vials, injection 450mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #12319

Manufacturer usually replies in 5 days

carboplatin

Injection 150 mg , 450 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #22283

Manufacturer usually replies in 4 days

carboplatin

Solution for infusion 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
PICS
Manufacturer #21567

Manufacturer usually replies in 2 days

carboplatin

Injection 150 mg, 450 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21249

Manufacturer usually replies in 5 days

carboplatin

Injection 150 mg, 450 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20510

Manufacturer usually replies in 2 days

carboplatin

Injection 150 mg/15 ml, 450 mg/45 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19783

Manufacturer usually replies in 2 days

carboplatin

Injection 150 mg, 450 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19664

Manufacturer usually replies in 5 days

carboplatin

Solution for injection 150 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
WHO
Manufacturer #15160

Manufacturer usually replies in 5 days

carboplatin

Vials, injection 150mg, 450mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Unavailable markets
Costa Rica
Manufacturer #678
It is situated in the southern part of South America. It is committed to excellence and continuous improvement. They have a production plant for the manufacturing of high value-added products like the treatment of HIV-AIDS and neurodegenerative and cardiovascular diseases.

Manufacturer usually replies in 3 days

carboplatin

Solution for injection 10MG/ML

Dossier type
CTD
Dossier status
Under development
Country of origin
India
Manufacturer #13085

Manufacturer usually replies in 4 days

carboplatin

Injection 150 mg, 450 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21110

Manufacturer usually replies in 6 days

carboplatin

Injection 50 mg, 100 mg, 450 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #20956
It is specialized in the human healthcare field, and has been manufacturing, marketing, and selling pharmaceutical products since the 1980s. They have a broad range of products from OTC, ETC including about 30 kinds of anti-cancer products.

Manufacturer usually replies in 8 days

carboplatin

Injection 50 mg, 150 mg, 450 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

carboplatin

Injection 10 ml, 15 ml, 45 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20087

Manufacturer usually replies in 8 days

carboplatin

Vials, injection 450mg/45ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, INVIMA
Manufacturer #18529

Manufacturer usually replies in 8 days

Want to view all 48 products? Create your free account today!

Carboplatin Methyl

Carboplatin is a chemotherapy agent used in treating certain sorts of cancer. The parent compound is cisplatin, Carboplatin is a kind of platinum anti-cancer compound. Carboplatin has achieved a significant reputation since its introduction back in the 1980s because it causes fewer side effects than cisplatin.

How does Carboplatin work?

Carcinoid tumors are characterized by cell division that is no longer as organized as in normal tissues. Normal cell stops dividing when they are in contact with cells similar to this, a process is known as contact inhibition. Cancer cells lose this ability. The process of cell division, whether normal or cancerous cells, takes place through the cell cycle. The cell cycle moves from the resting phase, through the phases of active growth, and then to mitosis (mitosis). The ability of chemotherapy to kill cancer cells depends on its ability to stop the cells from dividing. Drugs usually work by damaging RNA or DNA which tells the cell how to copy itself in case of division. Cells die if they’re unable to divide. If the cells divide faster, it is likely the chemotherapy will kill the cells, causing the tumor to shrink. They also induce cell suicide (self-death or programmed cell death). Chemotherapy drugs that affect cells only when they divide are called a specific cell cycle. The scheduling of chemotherapy is determined based on the type of cells, the rate of division, and the time that a particular drug is likely to be effective. This is why chemotherapy is usually given in cycles. Chemotherapy is very powerful at killing rapidly dividing cells. Unfortunately, chemotherapy does not know the difference between cancerous cells and healthy cells. The normal cells will grow again and be healthy but in the meantime, side effects occur. The normal cells most affected by chemotherapy are blood cells, cells of the mouth, stomach, intestines, and hair follicles. Leading to low blood counts, mouth sores, nausea, diarrhea, and/or hair loss. Different medicines may affect different parts of the body. Chemotherapy (anti-tumor drugs) falls into five categories based on how they work to kill cancer. Although these medicines are divided into groups, there is some overlap between some of the specific medicines.

Types of chemotherapy:

Alkylsulfonates: Busulfan. Ethylenimines: Hexamethylmelamine and Thiotepa. Mustard gas derivatives: Cyclophosphamide, Mechlorethamine, Melphalan, Chlorambucil, and Ifosfamide. Metal salts: Cisplatin, Carboplatin, and Oxaliplatin. Hydrazines and Triazines: Dacarbazine, Temozolomide, and Procarbazine. Nitrosoureas: Streptozocin, Lomustine, and Carmustine. Nitrosoureas are unique because, unlike most chemotherapy, they can cross the blood-brain barrier.

Carboplatin Side Effects:

Here are some examples of the side effects that may occur while carboplatin treatment: Diarrhea Nausea and vomiting Loss of appetite and Mouth ulcers Kidney and liver function may also be affected Hearing loss may be noticed, especially in children taking the treatment Hair loss

How much money does Carboplatin cost?

The retail prices per 5ml of 10mg/ml carboplatin injectable solution fall into an approximate range of 8.00 EUR to 12.00 EUR, whereas 60 ml vial of 10mg/ml carboplatin can cost around 60-70 EUR.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of carboplatin offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for carboplatin manufacturers and carboplatin suppliers that you are looking for. These also enable you to check the dossier status of Carboplatin, and the GMP approvals of the different variants of Carboplatin. Also, each manufacturer or supplier product description contains essential information about carboplatin including clinical data, stability zones, countries where carboplatin is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Ivermectin offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that Ivermectin manufacturers have, we qualify their companies before they are onboarded on the platform. This allows us to screen Ivermectin manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.